TELLA INC
TSE
2191

2191
TELLA INC
TSE
 
Next Earning
Market Cap
EPS
Div Yield
P/E
Next Earning
Market Cap
EPS
Div Yield
P/E

2191 Stock Chart

Financials

Valuation
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Margins
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
EBITDA, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM

Profile

Sector: Health Technology
Industry: Pharmaceuticals: Other
Employees: 36
tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following business segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment involves in the provision of cancer treatment technologies and chiefly the dendritic cell vaccine therapy. The Medical Support segment deals with the operation of cell processing facilities by contract, sales of cell processing devices and also provides the genetic diagnosis support business. The Pharmaceuticals segment handles the development activities for the purpose of receiving pharmaceutical approval of the DC vaccine as a regenerative medicine product for treating cancer. It also provides the consultation on the establishment and maintenance of cell processing centers (CPC); introduction of management systems for cell cultivation; lease of SOP (standard operating procedure) and regular checks on manufacturing operation management and training of cell cultivation technicians. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan.

News

Home Stock Screener Forex Screener Crypto Screener Economic Calendar Shows How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Refer a friend My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out